The oxidation of dopamine and epinine by the two forms of monoamine oxidase from rat liver

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 233-238

  Strolin Benedetti, M ^a   Sanson, G ^a   Bona, L ^a   Gallina, M ^a   Persiani, S ^a   Tipton, K F ^b  

^a Zambon Group SpA   (Italy)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; EPININE; AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; ISOENZYME;

ANIMAL CELL; ARTICLE; DEAMINATION; ENZYME SUBSTRATE; LIVER; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; ANIMAL; ENZYME SPECIFICITY; ENZYMOLOGY; KINETICS; METABOLISM; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; CLORGYLINE; DEOXYEPINEPHRINE; DOPAMINE; ISOENZYMES; KINETICS; LIVER; MALE; MONOAMINE OXIDASE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY;

EID: 0031636861     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_22     Document Type: Article

References (13)

1. Boomsma F, van Woerkens LJ, Man in't Veld AJ, Verdouw PD, Schalekamp MADH (1993) High activity of semicarbazide-sensitive amine oxidase (SSAO): an important source of errors in the determination of the concentration of dopamine in pig plasma. J Cardiovasc Pharm 22: 198-202
2. Fowler CJ, Tipton KF (1984) On the substrate specificities of the two forms of monoamine oxidase. J Pharm Pharmacol 36: 111-115
3. Hall TR, Figueroa HR, Newton DK, Yurgens PB (1983) Thermal inactivation of mouse brain monoamine oxidase type A and type B. Gen Pharmacol 14: 681-684
4. Husseini H, Mitrovic V, Schlepper M (1995) Determination of monoamine oxidase B activity by high-performance liquid chromatography with electrochemical detection. J Chromatogr 672: 138-142
5. Lodola E, Borgia M, Longo A, Pocchiari F, Pataccini R, Sher D (1986) Ibopamine kinetics after a single oral dose in healthy volunteers. Arzneimittelforschung/Drug Res 36: 345-348
6. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275
7. Mena MA, Aguado EG, de Yebenes JG (1984) Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method. Acta Neurol Scand 69: 218-225
8. O'Carroll AM, Bardsley ME, Tipton KF (1986) The oxidation of adrenaline and noradrenaline by the two forms of monoamine oxidase from human and rat brain. Neurochem Int 8: 493-500
9. Pocchiari F, Pataccini R, Castelnovo P, Longo A, Casagrande C (1986a) Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats. Arzneimittelforschung/Drug Res 36: 334-340
10. Pocchiari F, Pataccini R, Castelnovo P, Longo A, Paro M, Casagrande C (1986b) Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs. Arzneimittelforschung/Drug Res 36: 341-344
11. Scriba GKE, Borchardt RT (1989) Metabolism of catecholamine esters by cultured bovine brain microvessel endothelial cells. J Neurochem 53: 610-615
12. Strolin Benedetti M, Dostert P, Guffroy C, Tipton KF (1983) Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236. Mod Probl Pharmacopsychiat 19: 82-104
13. Wiseman-Distler MH, Sourkes TL, Carabin S (1965) Precursors of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the rat. Clin Chim Acta 12: 335-339